The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparison of the medical costs between active surveillance and other treatment for early prostate cancer in Japan: From the data of PRIAS JAPAN study.
 
Takuma Kato
No Relationships to Disclose
 
Mikio Sugimoto
Honoraria - Astellas Pharma; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb Japan; Chugai Pharma; Janssen; Kissei Pharmaceutical; Nippon Shinyaku; Novartis; Pfizer; Takeda
 
Yoshiyuki Kakehi
No Relationships to Disclose
 
Yoichiro Tohi
No Relationships to Disclose
 
Ryuji Matsumoto
No Relationships to Disclose
 
Nobuo Shinohara
Honoraria - Astellas Pharma; AstraZeneca; Janssen; MSD; Novartis; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Ono Pharmaceutical (Inst)
 
Akira Yokomizo
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Sanofi
Consulting or Advisory Role - Bayer; Janssen
Travel, Accommodations, Expenses - Sanofi
 
Hiroshi Fukuhara
No Relationships to Disclose
 
Koji Mitsuzuka
No Relationships to Disclose
 
Hiroshi Sasaki
No Relationships to Disclose
 
Shin Egawa
No Relationships to Disclose
 
Junichi Inokuchi
No Relationships to Disclose
 
Masatoshi Eto
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Eisai; Johnson & Johnson; Merck; Ono Pharmaceutical; Pfizer; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Janssen Oncology; Merck; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Takeda (Inst)